Nula Therapeutics Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
14
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$20.5M
- Investors
-
4
Nula Therapeutics General Information
Description
Operator of a biotechnology platform intended to develop therapies for metabolic dysfunction and age-related diseases through nuclear envelope targeting. The company offers small-molecule drug candidates focused on chronic disease treatment and healthspan research, enabling pharmaceutical researchers and healthcare providers to access novel therapeutic approaches for metabolic and age-related conditions.
Contact Information
Website
www.nulatx.comCorporate Office
- 961 Arlington Avenue North
- St. Petersburg, FL 33705
- United States
Corporate Office
- 961 Arlington Avenue North
- St. Petersburg, FL 33705
- United States
Nula Therapeutics Timeline
Nula Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Grant | 24-Feb-2026 | $20.5M | Completed | Clinical Trials - Phase 1 | ||
| 2. Later Stage VC (Series 1) | Completed | Clinical Trials - Phase 1 | ||||
| 1. Seed Round | 18-Mar-2026 | $7.4M | $7.4M | Completed | Clinical Trials - Phase 1 |
Nula Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-3 | ||||||||
| Seed-2 | ||||||||
| Seed | 4,281,288 | $0.000100 | $0.7 | $0.7 | 1x | $0.7 | 20.99% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Nula Therapeutics Signals
Nula Therapeutics Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Apollo Health Ventures | Venture Capital | Minority | ||
| GIMIC Ventures | Venture Capital | Minority | ||
| Korify Capital | Venture Capital | Minority | ||
| ARPA-H | Government |
Nula Therapeutics FAQs
-
When was Nula Therapeutics founded?
Nula Therapeutics was founded in 2021.
-
Where is Nula Therapeutics headquartered?
Nula Therapeutics is headquartered in St. Petersburg, FL.
-
What is the size of Nula Therapeutics?
Nula Therapeutics has 14 total employees.
-
What industry is Nula Therapeutics in?
Nula Therapeutics’s primary industry is Biotechnology.
-
Is Nula Therapeutics a private or public company?
Nula Therapeutics is a Private company.
-
What is Nula Therapeutics’s current revenue?
The current revenue for Nula Therapeutics is .
-
How much funding has Nula Therapeutics raised over time?
Nula Therapeutics has raised $17.4M.
-
Who are Nula Therapeutics’s investors?
Apollo Health Ventures, GIMIC Ventures, Korify Capital, and ARPA-H have invested in Nula Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process